CEPT

ANALYST NOTE: CEPT (Cantor Equity Partners II, Inc.) Date: 2026-06-13 Price: $11.11

1. Structural Readiness

• State: Context-only.
• Conservative Entry: Not yet defined (awaiting confirmed breakout).
• Aggressive/Pre-breakout Entry: N/A (Current price is $11.11, but this is a "forming" state, not a confirmed entry signal).
• Breakout Level: Not yet established (requires price to close decisively above the immediate consolidation high).
• Current Price: $11.11.
• Extension: N/A (No confirmed breakout to measure extension from).
• ATR Context: Current ATR is 5.7% (High). This indicates elevated volatility, which is typical for SPACs approaching a merger vote or liquidation deadline, but requires careful position sizing if a breakout occurs.

2. Thesis Layer

• Thesis Classification: TACTICAL / SETUP-LED.
• Macro Thesis: There is NO named secular thesis attached to this name as of 2026-06-13.
• Judgment Criteria: The investment case must be judged strictly on the quality of the technical setup (the "coil" formation) and the fundamental progress of the business combination with the target, rather than any broader macroeconomic tailwinds. Do not invent a thesis; the setup is the primary driver.

3. The Business

• Entity Type: Cantor Equity Partners II, Inc. is a Special Purpose Acquisition Company (SPAC).
• Core Mission: To consummate a business combination with one or more target enterprises.
• Target Focus: Management has stated a focus on companies in Financial Services, Digital Assets, Healthcare, Real Estate Services, Technology, and Software (Evidence E3, E8).
• Current Status of Combination:
• Target Identified: The company entered into a Business Combination Agreement on October 27, 2025, with Securitize, Inc. (a Delaware corporation) and its affiliates (Evidence E2, E9).
• Timeline: The IPO closed on May 5, 2025, generating $240 million in gross proceeds (24,000,000 shares at $10.00) (Evidence E4).
• Deadline: Management has until May 5, 2027, to consummate the combination. As of June 13, 2026, the company has approximately 11 months remaining to close the deal or face liquidation (Evidence E1, E7).
• Financial Position:
• Assets: As of March 31, 2026, total assets were approximately $248,999,000 (Evidence E6).
• Transaction Costs: Management expects to pay CF&Co. a cash fee of $8,400,000 upon consummation (Evidence E5).
• Forward Estimates: Forward consensus EPS for FY1 is projected at $0.10 and FY2 at $0.24 (Evidence E13).

4. Archetype and Conviction

• Archetype: Structural / Transactional.
• This is not a traditional operating business archetype (e.g., Growth Leader or Deep Value Recovery) but a vehicle awaiting a specific corporate event (the merger with Securitize).
• Valuation Context:
• The stock trades at $11.11, representing a ~11% premium to the $10.00 IPO price.
• The "Forward Consensus EPS" of $0.10 (FY1) suggests the market is pricing in a post-merger entity, though the merger has not yet closed.
• Conviction Stack:
• Thesis Strength: Low (No macro thesis; purely event-driven).
• Evidence Quality: Moderate. The target (Securitize) is identified, and the agreement is signed (Evidence E2, E9), but the deal is not yet closed.
• Structural Quality: The "Coil" is forming. The price is holding above the $10.00 floor, but the 5.7% ATR (High) suggests significant noise.
• Rerating Potential: Dependent entirely on the successful closing of the merger with Securitize.

5. Invalidations, Strengths, and Gaps

• Strengthening: A confirmed close above the immediate consolidation high (breakout) would confirm the "Active" state. Successful regulatory approval or shareholder vote for the merger would be a fundamental strengthener.
• Gaps in Evidence:
• Missing: No specific details on the *valuation* of the merger (e.g., implied enterprise value of Securitize).
• Missing: No details on the *pro forma* capital structure or specific dilution metrics post-merger.
• Missing: No recent earnings call transcript or specific management commentary on the *status* of the merger closing (e.g., regulatory hurdles) beyond the filing dates.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: low Key evidence: Business combination agreement with Securitize signed Oct 2025; Price holding above $10.00 IPO floor; 11 months remaining to close deal before May 2027 deadline. Key risks: Deal failure leading to liquidation at $10.00; High volatility (5.7% ATR) obscuring technical signals; No confirmed breakout yet; Forward EPS estimates are partial and unverified. Sizing hint: Minimal position size only if a confirmed breakout occurs; otherwise, avoid. Expected path: Price likely consolidates near $10.00-$11.50 range while management navigates merger closing; potential for sharp move upon deal announcement or failure. Expected horizon: 3 to 12 months (aligned with remaining deal timeline). Failure mode to watch: Daily close below $10.00.